ADC Therapeutics SA
ADCTNYSEHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $230.97M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.78$4.98
- Volume (live)
- -
- Avg. volume (3M)
- 1.66M
ADC Therapeutics SA (ADCT) Stock Price & Financial Analysis
ADC Therapeutics SA Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.40 - $1.51 |
|---|---|
| 52-Week High | $4.98 |
| 52-Week Low | $0.78 |
| Open | $1.49 |
| Volume (last close) | 799.51K |
| Average Volume (3M) | 1.66M |
| Revenue (TTM) | 79.58M |
|---|---|
| Net Income (TTM) | -96.91M |
| Free Cash Flow (TTM) | -102.32M |
| EPS (TTM) | −$0.68 |
| Profit Margin | -121.77% |
| Operating Margin | -121.22% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 230.97M |
|---|---|
| Shares Outstanding | 155.02M |
| Price to Sales (P/S) | 2.90 |
| Price to Book (P/B) | -1.01 |
| EV/EBITDA | -2.60 |
| 50-Day MA | $1.20 |
|---|---|
| 200-Day MA | $2.61 |
| 1-Year Change | −63.48% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
ADC Therapeutics SA at a Glance
As of the Oct 16, 2026 close, ADC Therapeutics SA (ADCT) has a market capitalization of $230.97M. The stock trades at 2.9× sales. Over the trailing twelve months it lost $96.91M on revenue of $79.58M and burned $102.32M of free cash flow. Revenue grew 3.0% year over year.
As of its latest reported balance sheet, it holds $219.11M in cash and securities against $116.62M of debt, a net cash position of $102.49M.
ADC Therapeutics SA does not currently pay a dividend.
The share price is down 63.5% over the past year. At $1.40 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.78 to $4.98, below its 200-day moving average of $2.61.
Based on 1 professional analyst rating from the past 90 days, the consensus is Hold.
Frequently Asked Questions About ADC Therapeutics SA
What is the current stock price for ADCT?
As of the Oct 16, 2026 close, ADCT stock trades at $1.40. The 52-week range is $0.78–$4.98, with a day range of $1.40–$1.51.
What is the P/E ratio for ADCT?
The P/E ratio (Price-to-Earnings) for ADCT is shown in the Key Statistics section. This valuation metric helps compare ADC Therapeutics SA to industry peers.
Does ADCT pay dividends?
ADC Therapeutics SA does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ADCT?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for ADCT is Hold.
What is the market cap of ADCT?
As of the Oct 16, 2026 close, ADC Therapeutics SA's market capitalization is $217.0M, classifying it as a micro-cap company. ADC Therapeutics SA operates in the Healthcare sector within the Biotechnology industry.